Mirae Asset Global Investments Co., Ltd. Kezar Life Sciences, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$0.8 - $1.05 $20,956 - $27,504	26,195 New	26,195 $23,000
Q1 2023 May 04, 2023	BUY	$3.13 - $7.31 $29,418 - $68,706	9,399 Added 33.66%	37,324 $116,000
Q4 2022 Feb 09, 2023	BUY	$6.39 - $8.8 $60,398 - $83,177	9,452 Added 51.17%	27,925 $196,000
Q3 2022 Nov 10, 2022	BUY	$7.99 - $10.75 $48,858 - $65,736	6,115 Added 49.48%	18,473 $159,000
Q2 2022 Jul 26, 2022	BUY	$4.58 - $17.13 $56,599 - $211,692	12,358 New	12,358 $102,000

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $446M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.